Our Mission

At HemoGuard, we are dedicated to saving lives in critical environments with our revolutionary blood substitute. Join us in transforming trauma care.

Meet Our Team

Discover the experts behind HemoGuard’s revolutionary technology, dedicated to saving lives.
Stephen Blignaut
CEO

With over 15 years of experience in biotechnology, Stephen Blignaut leads HemoGuard-SAFE with a passion for innovation and a commitment to saving lives.

Dr Keith Kwong
CTO
An expert in medical engineering, John oversees the development of our groundbreaking blood substitute technology.
Dr. Roel Galope
Lead Research Scientist
Dr. Chen specializes in hematology and is responsible for the clinical trials of our blood substitute.
Dr. Emil Shakof
Marketing Director
Michael brings over a decade of experience in biotech marketing, focusing on strategic partnerships.
Dr Mukesh Kumar
Regulatory Affairs Specialist
Sarah ensures compliance with medical regulations and oversees the approval processes for our products.
Dr. David Green
Clinical Advisor
Dr. Green provides insights from his extensive experience in emergency medicine to guide product development.
Claire Ironside
Operations Manager
Lisa oversees daily operations and ensures that our projects run smoothly and efficiently.
David Moses
Financial Analyst
David analyzes market trends and financial data to support HemoGuard’s growth strategies.

Join Our Mission

Be part of our journey to revolutionize trauma care and save lives.